Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Asset Writedowns and Impairment (2018 - 2024)

Historic Asset Writedowns and Impairment for Acadia Healthcare Company (ACHC) over the last 10 years, with Q2 2025 value amounting to $1.5 million.

  • Acadia Healthcare Company's Asset Writedowns and Impairment rose 4520.0% to $1.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year increase of 4120.27%. This contributed to the annual value of $17.3 million for FY2024, which is 7646.58% up from last year.
  • Latest data reveals that Acadia Healthcare Company reported Asset Writedowns and Impairment of $1.5 million as of Q2 2025, which was up 4520.0% from $5.8 million recorded in Q4 2024.
  • Over the past 5 years, Acadia Healthcare Company's Asset Writedowns and Impairment peaked at $23.2 million during Q2 2021, and registered a low of $1.0 million during Q2 2024.
  • Its 4-year average for Asset Writedowns and Impairment is $6.6 million, with a median of $3.6 million in 2024.
  • As far as peak fluctuations go, Acadia Healthcare Company's Asset Writedowns and Impairment tumbled by 9466.87% in 2021, and later skyrocketed by 43074.82% in 2024.
  • Acadia Healthcare Company's Asset Writedowns and Impairment (Quarter) stood at $1.1 million in 2021, then grew by 1.58% to $1.1 million in 2023, then surged by 430.75% to $5.8 million in 2024, then plummeted by 75.04% to $1.5 million in 2025.
  • Its Asset Writedowns and Impairment was $1.5 million in Q2 2025, compared to $5.8 million in Q4 2024 and $10.5 million in Q3 2024.